OM
JNCE

Opaleye Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Opaleye Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-669,944
Closed -$918K – 55
2023
Q2 		$918K Sell
669,944
-2,210,056
-77% -$3.03M 0.22% 42
2023
Q1 		$5.33M Buy
+2,880,000
New +$5.33M 1.6% 19